Phyto Animal Health, a subsidiary of Medical Marijuana Inc., which already produces cannabidiol (CBD) oils used to treat epilepsy in human children, is now marketing products for pets and livestock.
Greece is taking advantage of its warm climate to cultivate pot and create more than 2,000 jobs
I believe you have to hear the sounds of the foods calling to you – like the sound of the fizz when adding club soda to Sangria. Salutations and greetings from far Northern California, Hempie Chef here! Many Medical Marijuana patients here in Far Nor Cal medicate by consuming medical marijuana rather than smoking –…
The proposed law will permit the industrial production of cannabis products for medical use, opening up a new economic sector.
They wanted to see if the observed anti-inflammatory effects of cannabis also affect the development of liver disease. The study was led by Adeyinka Charles Adejumo of North Shore Medical Center in Salem, Massachusetts
The findings sounded alarming. But like any study, this one had key limitations, including the fact that it defined cannabis “users” as anyone who’d ever tried the drug. More importantly, however, it highlighted an important gap in our current understanding of the science of cannabis:
Advocates for medical marijuana have tried and failed in Virginia year after year. A few years ago, they persuaded lawmakers to allow it for epilepsy.
“The action is where the medical cannabis export markets are, which are much larger than Canada,” said Chris Damas, editor of the BCMI Cannabis Report. “CanniMed has patents, they have relationships with different universities, research and clinical trials, and export relations with other countries, and Aurora wants to add to their own relationships in Europe.”
The trial reduced the frequency of seizures in patients with the illness, just 10% of whom had previously been found to respond to conventional drug treatments, though the authors say that efficacy and safety of the new treatment ‘now needs to be confirmed’.
Cannabidiol restores intestinal barrier dysfunction and inhibits the apoptotic process induced by Clostridium difficile toxin A in Caco-2 cells
Clostridium difficile toxin A is responsible for colonic damage observed in infected patients. Drugs able to restore Clostridium difficile toxin A-induced toxicity have the potential to improve the recovery of infected patients. Cannabidiol is a non-psychotropic component of Cannabis sativa, which has been demonstrated to protect enterocytes against chemical and/or inflammatory damage and to restore intestinal mucosa integrity. Cannabidiol improved Clostridium difficile toxin A-induced damage in Caco-2 cells, by inhibiting the apoptotic process and restoring the intestinal barrier integrity, through the involvement of the CB1 receptor.